Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations

被引:113
作者
Kimmel, PL
Barisoni, L
Kopp, JB
机构
[1] George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20037 USA
[2] NIDDKD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.7326/0003-4819-139-3-200308050-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HIV infection is associated with several renal syndromes, including acute renal failure. Chronic renal failure directly linked to HIV infection includes thrombotic microangiopathic renal diseases, immune-mediated glomerulonephritides, and HIV-associated nephropathy. A renal biopsy may be necessary for diagnosis. The development of HIV-associated nephropathy has been definitively linked to renal cellular infection, but the disease affects only a minority of patients, typically men of African descent. Therefore, factors determining disease expression in infected patients must now be emphasized. The pathogenic mechanisms involved in HIV-associated renal disease remain obscure. Genetic factors, as well as renal cellular responses, mediated by HIV proteins (including an immune-activated microenvironment) capable of presenting antigen in susceptible hosts probably explain most cases. HIV-associated nephropathy has a characteristic pathologic phenotype, including glomerular, tubular, and interstitial changes, and ultrastructural findings. Infection of the glomerular epithelial cell, or podocyte, and consequent structural and biochemical changes may be pivotal in pathogenesis. The HIV-1 transgenic mouse is an important model for understanding disease pathogenesis, particularly the role of HIV proteins in mediating renal tissue injury. Rigorously controlled randomized trials have not evaluated treatment, but corticosteroids and angiotensin-converting enzyme inhibitors have been used. Highly active antiretroviral therapy seems to have decreased the incidence of end-stage renal disease related to HIV infection and, in case reports, to have improved renal functional and pathologic outcomes of HIV-associated nephropathy. Outcomes in patients undergoing hemodialysis and peritoneal dialysis have improved, and current research focuses on renal transplantation for treatment of HIV-infected patients.
引用
收藏
页码:214 / 226
页数:13
相关论文
共 144 条
[1]   Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States [J].
Ahuja, TS ;
Grady, J ;
Khan, S .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1889-1893
[2]   Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients [J].
Ahuja, TS ;
Borucki, M ;
Grady, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :574-580
[3]   Membranous glomerulonephritis with nephrotic syndrome in a HIV positive patient -: remarkable remission with triple therapy [J].
Alarcón-Zurita, A ;
Salas, A ;
Antón, E ;
Morey, A ;
Munar, MA ;
Losada, P ;
Martinez, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1097-1098
[4]   Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus [J].
Alpers, CE ;
Tsai, CC ;
Hudkins, KL ;
Cui, Y ;
Kuller, L ;
Benveniste, RE ;
Ward, JM ;
Morton, WR .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (05) :413-424
[5]   HUMAN MESANGIAL CELLS ARE RESISTANT TO PRODUCTIVE INFECTION BY MULTIPLE STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 [J].
ALPERS, CE ;
MCCLURE, J ;
BURSTEN, SL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (02) :126-130
[6]   Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy [J].
Alpers, CE ;
Madias, NE ;
Harrington, T ;
Levey, AS ;
Balakrishnan, V .
KIDNEY INTERNATIONAL, 2003, 63 (01) :385-396
[7]   Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy [J].
Bariéty, J ;
Nochy, D ;
Mandet, C ;
Jacquot, C ;
Glotz, D ;
Meyrier, A .
KIDNEY INTERNATIONAL, 1998, 53 (04) :918-925
[8]   Modulation of podocyte phenotype in collapsing glomerulopathies [J].
Barisoni, L ;
Kopp, JB .
MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 57 (04) :254-262
[9]  
Barisoni L, 1999, J AM SOC NEPHROL, V10, P51
[10]   Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies [J].
Barisoni, L ;
Mokrzycki, M ;
Sablay, L ;
Nagata, M ;
Yamase, H ;
Mundel, P .
KIDNEY INTERNATIONAL, 2000, 58 (01) :137-143